Articles tagged with: bCUBE

01June

The Hyris System™ can detect SARS-CoV-2 despite all the novel variants - Update

The Hyris System™ can detect SARS-CoV-2 despite all the novel variants - Update

As the new mutations of SARS-CoV-2 keep spreading world-wide, significant concerns increasingly worry both citizenship and the institutions. Even if some of these variants are innocuous, others may give the virus a selective advantage. Based on a risk assessment by major authorities involved in the fight against the spread of COVID-19, such as WHO, ECDC, CDC, these mutations are identified as Variants of Concern and monitored, alerting even more globally scientific and medical communities.

Posted in Technology, Research

22February

The Hyris System™ can detect SARS-CoV-2 despite all the novel variants

The Hyris System™ can detect SARS-CoV-2 despite all the novel variants

As the new mutations of SARS-CoV-2 keep spreading world-wide, significant concerns increasingly worry both citizenship and the institutions. Even if some of these variants are innocuous, others may give the virus a selective advantage. Based on a risk assessment by major authorities involved in the fight against the spread of COVID-19, such as WHO, ECDC, CDC, these mutations are identified as Variants of Concern and monitored, alerting even more globally scientific and medical communities.

Posted in Technology, Research

11February

Lallemand Health Solutions choose the Hyris System™ for their internal certification protocol

Lallemand Health Solutions choose the Hyris System™ for their internal certification protocol

We are excited to announce that Lallemand Health Solutions, a leading world-class probiotic manufacturer, chose the Hyris System™ for their internal certification protocol to produce and supply the best probiotic strains and products.

Posted in Technology, Research

31December

Evaluation of the diagnostic accuracy of a new point-of-care rapid test for SARS-CoV-2 virus detection

Evaluation of the diagnostic accuracy of a new point-of-care rapid test for SARS-CoV-2 virus detection

Hyris CE-IVD marked test for COVID human diagnostic "bKIT Virus Finder COVID-19" is at the core of the signature Article "Evaluation of the diagnostic accuracy of a new point-of-care rapid test for SARS-CoV-2 virus detection", from the Department of Laboratory Medicine of the National Institute for The Study and Treatment of Cancer IRCCS "Fondazione G Pascale" (IRCCS Pascale), of Naples (Italy)

Posted in Technology

20October

Industry Leaders Embrace Hyris' "Virus Finder System" to Keep Operations Running and Employees Safe

Industry Leaders Embrace Hyris'

Hyris bKIT Virus Finder Covid-19 is the first commercially available, rapid COVID-19 medical device approved by Health Canada for point-of-care human testing. Exclusively distributed by Songbird Life Science, it is fast becoming the preferred choice of industry leaders across Canada.

Posted in Technology

30September

PFS Partner Hyris Secures UK Triumph with Canadian Government 90-Minute COVID-19 Testing Megadeal

PFS Partner Hyris Secures UK Triumph with Canadian Government 90-Minute COVID-19 Testing Megadeal

Hyris bCUBE based test kit is the only authorised medical device approved for human tests in Point of Care currently commercially available in Canada. Hyris Ltd. now focuses on supporting Canada in fully facing the new virus escalation.

Posted in Technology

16June

Hyris Ltd first ranking for COVID-19 research fund program by Regione Lombardia

Hyris Ltd first ranking for COVID-19 research fund program by Regione Lombardia

Hyris Ltd first ranking for the Regione Lombardia COVID-19 Research fund with the project: COVES – Sviluppo e validazione di una metodica rapida per la rilevazione di SARS-CoV-2 su superfici ambientali

Posted in Technology, Research

18May

New article from our colleagues at Johns Hopkins University - Field-deployable molecular diagnostic platform for arbovirus and Wolbachia detection in Aedes aegypti.

New article from our colleagues at Johns Hopkins University - Field-deployable molecular diagnostic platform for arbovirus and Wolbachia detection in Aedes aegypti.

“Surveillance of mosquito infection status is critical for planning and deployment of proper mosquito control initiatives. Concurrently, Wolbachia is being widely used as a control method for arboviral transmission. Point-of-care (POC) detection assays are necessary for monitoring the infection prevalence and geographic range of viruses as well as Wolbachia in mosquito vector populations.“

Posted in Technology, Research

29April

Hyris Ltd on Immunological Reviews - Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment

Hyris Ltd on Immunological Reviews - Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment

We are proud of our last result, a publication on Immunological Reviews of the paper “Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment”.

Posted in Technology, Research

17April

Hyris and Purity-IQ: new strategic partnership

Hyris and Purity-IQ: new strategic partnership

Toronto based Purity-IQ Inc., has partnered exclusively with Hyris, a leader in Artificial Intelligence applications for advanced diagnostics with offices in London, Milan and Singapore, to support their business expansion in the Americas.

Posted in Products, Technology, Research

08April

Hyris COVID-19 Environmental Testing - Press Release

Hyris COVID-19 Environmental Testing - Press Release

The identification of infected surfaces is a key step to fight COVID-19 spreading.  Thanks to our new kit, the detection of COVID-19 Environmental contamination is now easy, fast and accurate.

Posted in Technology, Events

21February

Hyris & Generon - Analytica 2020

Hyris & Generon - Analytica 2020

Hyris Trade Fairs Analytica, March 31st to April 3rd 2020, Messe München

Posted in Technology, Events

13February

Indena Genetically Validates Bilberry Extract

Indena Genetically Validates Bilberry Extract

Various reports have estimated approximately 30% of biomass materials sold for human consumption are not what is declared on the label. As such, Indena has applied DNA barcoding to validate the content of its natural ingredients—starting with bilberry.

Posted in Products, Technology, Research

25June

Portable device detects dengue, Zika in individual mosquitoes

Portable device detects dengue, Zika in individual mosquitoes

SAN FRANCISCO — Researchers developed a highly sensitive quantitative PCR, or qPCR, method for the detection and quantitation of dengue and Zika virus in individual mosquitoes using the portable Hyris bCUBE device, introducing a new tool for mosquito surveillance in areas facing outbreaks, according to data presented at ASM Microbe.

Posted in Products, Technology, Research

24June

EMMAC to partner with Hyris Ltd to develop Unique Real-Time Phyto-Cannabinoid Rich technology for the specific identification of proprietary cultivars of Cannabis subsp

EMMAC to partner with Hyris Ltd to develop Unique Real-Time Phyto-Cannabinoid Rich technology for the specific identification of proprietary cultivars of Cannabis subsp

London, 24 June 2019: EMMAC, the European independent medical cannabis company, is pleased to announce an exclusive collaboration with Hyris Ltd, a UK-based biotechnology company, to develop a comprehensive library of genetic profiles of existing cannabis varieties, and to industrialise DNA-based methods for the identification of its unique branded cultivars.

 

Posted in Products, Technology, Research

[12  >>  

Newsletter

Subscribe our newsletter for periodical updates about our technologies

Address


Lower Ground Floor
One George Yard
EC3V 9DF - London, UK
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Social



Copyright © 2019 - Hyris Ltd // Powered by Amodeo Design